|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3487882 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17745951.8 |
| Date of filing the European patent application | 2017-07-20 | |
| (97) | Date of publication of the European application | 2019-05-29 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-16 |
| (46) | Date of publication of the claims translation | 2025-10-10 |
| (86) | Number | PCT/US2017/042982 |
| Date | 2017-07-20 |
| (87) | Number | WO 2018/017786 |
| Date | 2018-01-25 |
| (30) | Number | Date | Country code |
| 201662364811 P | 2016-07-20 | US |
| (72) |
ATTAR, Ricardo , US
CHIN, Diana , US
EDAVETTAL, Suzanne , US
GAUDET, Francois , US
LI, Yingzhe , US
LUISTRO, Leopoldo , US
MAJEWSKI, Nathan , US
MENDONCA, Mark , US
PILLARISETTI, Kondandaram , US
TEPLYAKOV, Alexey , US
TORNETTA, Mark , US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš GPRC5D, bispecifinį antigeną surišančios molekulės, prijungiančios GPRC5D ir CD3, ir jų naudojimas |
| ANTI- GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-10-03 | 9 | 312.00 EUR |
| 2026-07-20 |